-
Brazil ratifies EU-Mercosur trade deal
-
Real Sociedad edge rivals Athletic to reach Copa del Rey final
-
Chelsea boost top four push as Joao Pedro treble routs Villa
-
Leverkusen sink Hamburg to keep in touch with top four
-
Love match: WTA No. 1 Sabalenka announces engagement
-
Man City falter as Premier League leaders Arsenal go seven points clear
-
Man City title bid rocked by Forest draw
-
Defending champ Draper ready to ramp up return at Indian Wells
-
Arsenal extend lead in title race after Saka sinks Brighton
-
US, European stocks rise as oil prices steady; Asian indexes tumble
-
Trump rates Iran war as '15 out of 10'
-
Nepal votes in key post-uprising polls
-
US Fed warns 'economic uncertainty' weighing on consumers
-
Florida family sues Google after AI chatbot allegedly coached suicide
-
Alcaraz unbeaten run under threat from Sinner, Djokovic at Indian Wells
-
UK warship to leave for Cyprus next week: officials
-
Iran's supreme leader gone, but opposition still at war with itself
-
Spain denies US claim of military cooperation on Iran as rift deepens
-
Mideast war rekindles European fears over soaring gas prices
-
'Miracle to walk' says golfer after lift shaft fall
-
'Nothing is working': Gulf travel turmoil hits Berlin tourism fair
-
Harvey Weinstein rape retrial to start April 14: publicist
-
No choke but 'walloping', South Africa coach says of T20 flop
-
Bayer gets preliminary approval for weedkiller class settlement
-
Russia to free two Hungarian-Ukrainian POWs, Putin says
-
Michelangelo's works hidden in 'secret room', researcher says
-
Adidas shares slump on outlook, Mideast war casts shadow
-
'No to the war': Spain digs in as rift with US deepens
-
Ivory Coast cuts cocoa producer price by nearly 60 percent: govt
-
Berlin film festival chief to remain in job after Gaza row
-
Allen's record ton powers New Zealand into T20 World Cup final
-
Stocks firm, oil steadies after sell-off on Middle East turmoil
-
War in the Middle East: latest developments
-
Scotland's Steyn expects Six Nations 'fun' against France
-
Iran war exiles describe terror of daily strikes
-
Tudor tells Spurs that relegation battle isn't real pressure
-
UK MP's husband among three accused of spying for China
-
Argentine sub in 2017 implosion was seaworthy, trial told
-
Latest developments in Iran war: Bodies found after Iran warship hit
-
Jansen fifty lifts South Africa to 169-8 against New Zealand
-
Next week before UK warship heads to Cyprus: officials
-
Marseille mayor opposes Kanye West gig over 'unabashed Nazism'
-
At least 87 dead after US sinks Iranian warship
-
US says submarine sank Iranian warship off Sri Lanka
-
Farrell makes changes for Wales game, Gibson-Park set for 50th Ireland cap
-
Stocks firm, oil dips after sell-off on Middle East turmoil
-
Latest developments in Iran war: Israel plans on 'one, two weeks' of strikes
-
Turkey says missile launched from Iran destroyed by NATO
-
Starmer says US planes flying out of UK bases 'special relationship in action'
-
Hungary presses Russia not to hike energy prices amid Iran turmoil
AI helps fuel new era of medical self-testing
Beyond smart watches and rings, artificial intelligence is being used to make self-testing for major diseases more readily available -- from headsets that detect early signs of Alzheimer's to an iris-scanning app that helps spot cancer.
"The reason preventive medicine doesn't work right now is because you don't want to go to the doctor all the time to get things tested," says Ramses Alcaide, co-founder and CEO of startup Neurable.
"But what about if you knew when you needed to go to the doctor?"
Connected rings, bracelets and watches -- which were everywhere at last week's Consumer Electronics Show in Las Vegas -- can already monitor heart rate, blood pressure and glucose levels, with varying degrees of accuracy.
These gadgets are in high demand from consumers. A recent study published by OpenAI showed that more than 200 million internet users check ChatGPT every week for information on health topics.
On Wednesday, OpenAI even launched a chatbot that can draw on a user's medical records and other data collected by wearable devices, with their consent, to inform its responses.
Using electroencephalogram (EEG) technology, Neurable has developed a headset that records and deciphers brain activity.
The linked app compares data with the user's medical history to check for any deviation, a possible sign of a problem, said Alcaide.
"Apple Watch can pick up Parkinson's, but it can only pick it up once you have a tremor," Alcaide said. "Your brain has been fighting that Parkinson's for over 10 years."
With EEG technology, "you can pick these things up before you actually see physical symptoms of them. And this is just one example."
- Detection before symptoms -
Some people have reservations about the capabilities of such devices.
"I don't think that wearable EEG devices are reliable enough," said Anna Wexler, a University of Pennsylvania professor who studies consumer detection products, although she acknowledges that "AI has expanded the possibilities of these devices."
While Neurable's product cannot provide an actual diagnosis, it does offer a warning. It can also detect signs of depression and early development of Alzheimer's disease.
Neurable is working with the Ukrainian military to evaluate the mental health of soldiers on the front lines of the war with Russia, as well as former prisoners of war, in order to detect post-traumatic stress disorder (PTSD).
French startup NAOX meanwhile has developed EEG earbuds linked to a small box that can help patients with epilepsy.
Rather than detect seizures, which are "very rare," the device recognizes "spikes" -- quick, abnormal electrical shocks in the brain that are "much more difficult to see," said NAOX's chief of innovation Marc Vaillaud, a doctor by training.
NAOX's device -- which has been cleared by the US Food and Drug Administration -- is designed to be worn at night, to track several hours of data at a time.
The company is working with the Rothschild and Lariboisiere hospitals in Paris to try to better understand the links between these brain "spikes" and Alzheimer's disease, which have been raised in scientific papers.
Advances in AI and technology in general have paved the way for the miniaturization of cheaper detection devices -- a far cry from the heavy machinery once seen in medical offices and hospitals.
IriHealth is preparing to launch, for only about $50, a small smartphone extension that would scan a user's iris.
The gadget relies on iridology, a technique by which iris colors and markings are believed to reveal information about a person's health, but which is generally considered scientifically unreliable.
But the founders of IriHealth -- a spin-off of biometrics specialist IriTech -- are convinced that their device can be effective in detecting anomalies in the colon, and potentially the lungs or the liver.
Company spokesman Tommy Phan said IriHealth had found its device to be 81 percent accurate among patients who already have been diagnosed with colon cancer.
Th.Gonzalez--AT